Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Monoclonal Antibodies Reveal Dynamic Plasticity Between Lgr5- and Bmi1-Expressing Intestinal Cell Populations.

Smith NR, Swain JR, Davies PS, Gallagher AC, Parappilly MS, Beach CZ, Streeter PR, Williamson IA, Magness ST, Wong MH.

Cell Mol Gastroenterol Hepatol. 2018 Mar 10;6(1):79-96. doi: 10.1016/j.jcmgh.2018.02.007. eCollection 2018.

2.

Humanised recombinant antibody fragments bind human pancreatic islet cells.

Buenafe AC, Streeter PR.

J Immunol Methods. 2018 Aug;459:20-28. doi: 10.1016/j.jim.2018.05.006. Epub 2018 May 21.

PMID:
29758224
3.

Effects of erythropoietin receptor activity on angiogenesis, tubular injury, and fibrosis in acute kidney injury: a "U-shaped" relationship.

Shi M, Flores B, Li P, Gillings N, McMillan KL, Ye J, Huang LJ, Sidhu SS, Zhong YP, Grompe MT, Streeter PR, Moe OW, Hu MC.

Am J Physiol Renal Physiol. 2018 Apr 1;314(4):F501-F516. doi: 10.1152/ajprenal.00306.2017. Epub 2017 Nov 29.

4.

Glycoprotein 2 is a specific cell surface marker of human pancreatic progenitors.

Cogger KF, Sinha A, Sarangi F, McGaugh EC, Saunders D, Dorrell C, Mejia-Guerrero S, Aghazadeh Y, Rourke JL, Screaton RA, Grompe M, Streeter PR, Powers AC, Brissova M, Kislinger T, Nostro MC.

Nat Commun. 2017 Aug 24;8(1):331. doi: 10.1038/s41467-017-00561-0.

5.

Human islets contain four distinct subtypes of β cells.

Dorrell C, Schug J, Canaday PS, Russ HA, Tarlow BD, Grompe MT, Horton T, Hebrok M, Streeter PR, Kaestner KH, Grompe M.

Nat Commun. 2016 Jul 11;7:11756. doi: 10.1038/ncomms11756.

6.

New markers for tracking endoderm induction and hepatocyte differentiation from human pluripotent stem cells.

Holtzinger A, Streeter PR, Sarangi F, Hillborn S, Niapour M, Ogawa S, Keller G.

Development. 2015 Dec 15;142(24):4253-65. doi: 10.1242/dev.121020. Epub 2015 Oct 22.

7.

Novel surface markers directed against adult human gallbladder.

Galivo FH, Dorrell C, Grompe MT, Zhong Y, Streeter PR, Grompe M.

Stem Cell Res. 2015 Jul;15(1):172-81. doi: 10.1016/j.scr.2015.06.004. Epub 2015 Jun 11.

8.

The organoid-initiating cells in mouse pancreas and liver are phenotypically and functionally similar.

Dorrell C, Tarlow B, Wang Y, Canaday PS, Haft A, Schug J, Streeter PR, Finegold MJ, Shenje LT, Kaestner KH, Grompe M.

Stem Cell Res. 2014 Sep;13(2):275-83. doi: 10.1016/j.scr.2014.07.006. Epub 2014 Jul 27.

9.

Pillars article: Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science. 1994. 264: 703-707.

De Togni P, Goellner J, Ruddle NH, Streeter PR, Andrea F, Mariathasan S, Smith SC, Carlson R, Shornick LP, Strauss-Schoenberger J, Russell JH, Karr R, Chaplin DD.

J Immunol. 2014 Mar 1;192(5):2010-4. No abstract available.

10.

Epigenomic plasticity enables human pancreatic α to β cell reprogramming.

Bramswig NC, Everett LJ, Schug J, Dorrell C, Liu C, Luo Y, Streeter PR, Naji A, Grompe M, Kaestner KH.

J Clin Invest. 2013 Mar;123(3):1275-84. doi: 10.1172/JCI66514. Epub 2013 Feb 22.

11.

Human pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasia.

Morgan TK, Hardiman K, Corless CL, White SL, Bonnah R, Van de Vrugt H, Sheppard BC, Grompe M, Cosar EF, Streeter PR.

Cancer Cytopathol. 2013 Jan;121(1):37-46. doi: 10.1002/cncy.21223. Epub 2012 Jul 18.

12.

Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress.

Gold MC, Eid T, Smyk-Pearson S, Eberling Y, Swarbrick GM, Langley SM, Streeter PR, Lewinsohn DA, Lewinsohn DM.

Mucosal Immunol. 2013 Jan;6(1):35-44. doi: 10.1038/mi.2012.45. Epub 2012 Jun 13.

13.

The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma.

Hooper JE, Morgan TK, Grompe M, Sheppard BC, Troxell ML, Corless CL, Streeter PR.

Hum Pathol. 2012 Oct;43(10):1583-9. doi: 10.1016/j.humpath.2011.11.012. Epub 2012 Mar 9.

14.

Pretargeting vs. direct targeting of human betalox5 islet cells subcutaneously implanted in mice using an anti-human islet cell antibody.

Liu G, Dou S, Akalin A, Rusckowski M, Streeter PR, Shultz LD, Greiner DL.

Nucl Med Biol. 2012 Jul;39(5):645-51. doi: 10.1016/j.nucmedbio.2011.12.001. Epub 2012 Feb 10.

15.

Transcriptomes of the major human pancreatic cell types.

Dorrell C, Schug J, Lin CF, Canaday PS, Fox AJ, Smirnova O, Bonnah R, Streeter PR, Stoeckert CJ Jr, Kaestner KH, Grompe M.

Diabetologia. 2011 Nov;54(11):2832-44. doi: 10.1007/s00125-011-2283-5. Epub 2011 Sep 1. Erratum in: Diabetologia. 2013 May;56(5):1192.

16.

Isolation of mouse pancreatic alpha, beta, duct and acinar populations with cell surface markers.

Dorrell C, Grompe MT, Pan FC, Zhong Y, Canaday PS, Shultz LD, Greiner DL, Wright CV, Streeter PR, Grompe M.

Mol Cell Endocrinol. 2011 Jun 6;339(1-2):144-50. doi: 10.1016/j.mce.2011.04.008. Epub 2011 Apr 22.

17.

Human islet cell MORF/cMORF pretargeting in a xenogeneic murine transplant model.

Liu G, Dou S, Cheng D, Leif J, Rusckowski M, Streeter PR, Shultz LD, Hnatowich DJ, Greiner DL.

Mol Pharm. 2011 Jun 6;8(3):767-73. doi: 10.1021/mp100382m. Epub 2011 Apr 21.

18.

The potential of human allogeneic juvenile chondrocytes for restoration of articular cartilage.

Adkisson HD 4th, Martin JA, Amendola RL, Milliman C, Mauch KA, Katwal AB, Seyedin M, Amendola A, Streeter PR, Buckwalter JA.

Am J Sports Med. 2010 Jul;38(7):1324-33. doi: 10.1177/0363546510361950. Epub 2010 Apr 27.

19.

Immune evasion by neocartilage-derived chondrocytes: Implications for biologic repair of joint articular cartilage.

Adkisson HD, Milliman C, Zhang X, Mauch K, Maziarz RT, Streeter PR.

Stem Cell Res. 2010 Jan;4(1):57-68. doi: 10.1016/j.scr.2009.09.004. Epub 2009 Sep 25.

20.

Generation of monoclonal antibodies specific for cell surface molecules expressed on early mouse endoderm.

Gadue P, Gouon-Evans V, Cheng X, Wandzioch E, Zaret KS, Grompe M, Streeter PR, Keller GM.

Stem Cells. 2009 Sep;27(9):2103-13. doi: 10.1002/stem.147.

21.

Isolation of major pancreatic cell types and long-term culture-initiating cells using novel human surface markers.

Dorrell C, Abraham SL, Lanxon-Cookson KM, Canaday PS, Streeter PR, Grompe M.

Stem Cell Res. 2008 Sep;1(3):183-94. doi: 10.1016/j.scr.2008.04.001. Epub 2008 May 8.

22.

Hematopoietic stem cells contribute to lymphatic endothelium.

Jiang S, Bailey AS, Goldman DC, Swain JR, Wong MH, Streeter PR, Fleming WH.

PLoS One. 2008;3(11):e3812. doi: 10.1371/journal.pone.0003812. Epub 2008 Nov 26.

23.

Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease.

Kovacsovics-Bankowski M, Streeter PR, Mauch KA, Frey MR, Raber A, van't Hof W, Deans R, Maziarz RT.

Cell Immunol. 2009;255(1-2):55-60. doi: 10.1016/j.cellimm.2008.10.004. Epub 2008 Nov 20.

PMID:
19022422
24.

Pre-clinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cells.

Kovacsovics-Bankowski M, Mauch K, Raber A, Streeter PR, Deans RJ, Maziarz RT, Van't Hof W.

Cytotherapy. 2008;10(7):730-42. doi: 10.1080/14653240802320245.

PMID:
18985479
25.

Surface markers for the murine oval cell response.

Dorrell C, Erker L, Lanxon-Cookson KM, Abraham SL, Victoroff T, Ro S, Canaday PS, Streeter PR, Grompe M.

Hepatology. 2008 Oct;48(4):1282-91. doi: 10.1002/hep.22468.

26.

Modification of the Woodruff-Stamper assay demonstrates binding of Toxoplasma gondii tachyzoites to retinal vascular endothelium.

Chipps TJ, Streeter PR, Franc DT, Neumeyer K, Planck SR, Rosenbaum JT, Smith JR.

J Immunol Methods. 2006 May 30;312(1-2):209-13. Epub 2006 Apr 27.

PMID:
16725152
27.

Donor marker infidelity in transgenic hematopoietic stem cells.

Anderson DA, Wu Y, Jiang S, Zhang X, Streeter PR, Spangrude GJ, Archer DR, Fleming WH.

Stem Cells. 2005 May;23(5):638-43.

28.

CD25 expression distinguishes functionally distinct alloreactive CD4 CD134 (OX40) T-cell subsets in acute graft-versus-host disease.

Streeter PR, Zhang X, Tittle TV, Schön CN, Weinberg AD, Maziarz RT.

Biol Blood Marrow Transplant. 2004 May;10(5):298-309.

29.

Activation of the G-CSF and Flt-3 receptors protects hematopoietic stem cells from lethal irradiation.

Streeter PR, Dudley LZ, Fleming WH.

Exp Hematol. 2003 Nov;31(11):1119-25.

PMID:
14585378
30.

Characterization of dendritic cells generated in vivo by an E. coli derived chimeric dual receptor agonist.

Kahn LE, Doshi PD, McGarity KL, Yu M, Bono CP, Lie WR, Rankin AM, Smidt ML, Streeter PR, Klein BK, Welply JK, Woulfe SL.

Med Sci Monit. 2002 Dec;8(12):BR504-14.

PMID:
12503028
32.

Dendritic cells generated in vivo by a chimeric hematopoietic growth factor, progenipoietin-4, demonstrate potent immunological function.

Ishioka GY, Fikes J, Qin M, Gianfrani C, Chesnut RW, Kahn LE, Streeter PR, Woulfe SL, Sette A.

Vaccine. 2001 Jun 14;19(27):3710-9.

PMID:
11395205
33.

Progenipoietins: biological characterization of a family of dual agonists of fetal liver tyrosine kinase-3 and the granulocyte colony-stimulating factor receptor.

Streeter PR, Minster NI, Kahn LE, Hood WF, Vickery LE, Thurman TL, Monahan JB, Welply JK, McKearn JP, Woulfe SL.

Exp Hematol. 2001 Jan;29(1):41-50.

PMID:
11164104
34.

Murine isograft studies of gut immunity: recirculation and homing of mononuclear cells.

Okuyama S, Rubin D, Streeter PR, Peters M.

Gastroenterology. 1997 Apr;112(4):1241-9.

PMID:
9098008
35.

Her story: Phillys Streeter (nee Wright) RGN, maternity nurse. Interview by Lynette Low.

Streeter P.

Nurs Prax N Z. 1997 Mar;12(1):29-30. No abstract available.

PMID:
9275779
36.
37.
38.

Estimating milk intake of hospitalized preterm infants who breastfeed.

Meier PP, Engstrom JL, Fleming BA, Streeter PL, Lawrence PB.

J Hum Lact. 1996 Mar;12(1):21-6.

PMID:
8715234
39.

Expression of the mucosal vascular addressin, MAdCAM-1, on sinus-lining cells in the spleen.

Kraal G, Schornagel K, Streeter PR, Holzmann B, Butcher EC.

Am J Pathol. 1995 Sep;147(3):763-71.

40.
41.

Enzymatic synthesis of a 6'-sulphated sialyl-Lewisx which is an inhibitor of L-selectin binding to peripheral addressin.

Scudder PR, Shailubhai K, Duffin KL, Streeter PR, Jacob GS.

Glycobiology. 1994 Dec;4(6):929-32.

PMID:
7537558
42.

Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin.

De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, Smith SC, Carlson R, Shornick LP, Strauss-Schoenberger J, et al.

Science. 1994 Apr 29;264(5159):703-7.

PMID:
8171322
43.

The human peripheral lymph node vascular addressin. An inducible endothelial antigen involved in lymphocyte homing.

Michie SA, Streeter PR, Bolt PA, Butcher EC, Picker LJ.

Am J Pathol. 1993 Dec;143(6):1688-98.

44.

Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium.

Hänninen A, Taylor C, Streeter PR, Stark LS, Sarte JM, Shizuru JA, Simell O, Michie SA.

J Clin Invest. 1993 Nov;92(5):2509-15.

45.

Developmental regulation of vascular addressin expression: a possible role for site-associated environments.

Mebius RE, Brevé J, Kraal G, Streeter PR.

Int Immunol. 1993 May;5(5):443-9.

PMID:
8318450
46.

Preclinical evaluation of human hematolymphoid function in the SCID-hu mouse.

McCune JM, Péault B, Streeter PR, Rabin L.

Immunol Rev. 1991 Dec;124:45-62. Review.

PMID:
1804780
47.

The influence of afferent lymphatic vessel interruption on vascular addressin expression.

Mebius RE, Streeter PR, Brevé J, Duijvestijn AM, Kraal G.

J Cell Biol. 1991 Oct;115(1):85-95.

48.

Differential expression of homing-associated adhesion molecules by T cell subsets in man.

Picker LJ, Terstappen LW, Rott LS, Streeter PR, Stein H, Butcher EC.

J Immunol. 1990 Nov 15;145(10):3247-55.

PMID:
1700003
50.

Inducible expression of an endothelial cell antigen on murine myocardial vasculature in association with interstitial cellular infiltration.

Leppink DM, Bishop DK, Sedmak DD, Henry ML, Ferguson RM, Streeter PR, Butcher EC, Orosz CG.

Transplantation. 1989 Nov;48(5):874-7. No abstract available.

PMID:
2683264

Supplemental Content

Loading ...
Support Center